Join Valneva SE Class Action Lawsuit: VALN Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Valneva SE (NASDAQ: VALN) concerning potential violations of the federal securities laws.

On February 25, 2025, the U.S. Centers for Disease Control and Prevention ("CDC") posted a notice on its website announcing that "CDC is currently investigating five hospitalizations for cardiac or neurologic events following vaccination with IXCHIQ [Valneva's chikungunya virus vaccine] among people 65 years of age and older." Following this announcement and subsequent reporting by media outlets, Valneva's American Depositary Receipt ("ADR") price fell over 13% on February 28, 2025.

If you suffered a loss on your Valneva SE securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Valneva SE which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Valneva SE. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Digimarc Corporation Class Action Lawsuit: DMRC Lawsuit Sign Up Form

Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Digimarc Corporation (NASDAQ: DMRC) securities.

If you suffered a loss on your Digimarc investment and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

THE LAWSUIT: May 02 2024 - Feb 26 2025

CASE DETAILS: The filed complaint alleges that Digimarc Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) a large commercial partner would not renew a large contract on the same terms; (2) as a result, Digimarc would renegotiate the large commercial contract; (3) as a result of the foregoing, the Company’s subscription revenue and annual recurring revenue would be adversely affected; (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Digimarc Corporation which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Digimarc Corporation. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join IonQ, Inc. Class Action Lawsuit: IONQ Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into IonQ, Inc. (NYSE: IONQ) concerning potential violations of the federal securities laws.

On February 26, 2025, IONQ reported positive revenue results for Q4 2024 financial results. However, earnings per share totaled a loss of 93 cents per share, falling 68 cents per share below analysts' estimates. IONQ also announced a CEO transition. Following this news, IONQ’s stock price fell by $5.02 per share, or approximately 17%, to close at $24.91 per share.

If you suffered a loss on your IonQ, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in IonQ, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against IonQ, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Teleflex Incorporated Class Action Lawsuit: TFX Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Teleflex Incorporated (NYSE: TFX) concerning potential violations of the federal securities laws.

On February 27, 2025, Fierce Biotech published an article entitled "Teleflex plays musical chairs, plans company split amid €760M Biotronik cardiovascular deal." The article stated that "Teleflex has announced a plan to split its business into two separate independent companies-and it's setting up one of its future scions with a new portfolio of cardiovascular device assets, set to be acquired from Biotronik." Following this news, Teleflex's stock fell over 21% on the same day.

If you suffered a loss on your Teleflex Incorporated securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Teleflex Incorporated which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Teleflex Incorporated. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Sempra Class Action Lawsuit: SRE Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Sempra (NYSE: SRE) concerning potential violations of the federal securities laws.

Before the market opened, Sempra released its fourth-quarter and full-year 2024 financial results on February 25, 2025, reporting annual revenue of $3.76 billion—falling $970 million short of consensus estimates. The company also lowered its 2025 earnings guidance to a midpoint of $4.50 per share, down from the previous $5.00 per share outlook. Sempra attributed the disappointing results to “higher interest and operating expenses and lower consumption primarily due to mild weather.” Following this news, Sempra’s stock price dropped over 19% on the same day, causing investor losses.

If you suffered a loss on your Sempra securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Sempra which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Sempra. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Akamai Technologies, Inc. Class Action Lawsuit: AKAM Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Akamai Technologies, Inc. (NASDAQ: AKAM) concerning potential violations of the federal securities laws.

Akamai issued a press release on February 20, 2025, reporting its financial results for the fourth quarter and full year 2024. Although Akamai reported better-than-expected revenue and earnings per share ("EPS"), the Company also provided revenue and EPS guidance for the current quarter and full year that fell short of consensus estimates. Following Akamai's disappointing guidance, analysts variously expressed concerns about the Company's future and downgraded its stock. Following this news, Akamai's stock price fell over 21% on February 21, 2025.

If you suffered a loss on your Akamai Technologies, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Akamai Technologies, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Akamai Technologies, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join HelloFresh SE Class Action Lawsuit: HLFFF Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into HelloFresh SE (OTC PINK: HLFFF) concerning potential violations of the federal securities laws.

HelloFresh is the subject of an ABC News report published on December 6, 2024, titled: "Labor Department investigating migrant child labor claims at HelloFresh." According to the report, "The U.S. Department of Labor is investigating HelloFresh, the popular meal kit service company, over allegations that migrant children were working at its cooking and packaging facility in Illinois as recently as this summer, ABC News has learned." ABC added, "At least six teenagers, at least some of whom migrated from Guatemala, were found working night shifts at the facility, said Cristobal Cavazos, the executive director for Immigrant Solidarity, an immigrant rights advocacy group that helped report the matter to federal regulators." The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

If you suffered a loss on your HelloFresh SE securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in HelloFresh SE which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against HelloFresh SE. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Parsons Corporation Class Action Lawsuit: PSN Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Parsons Corporation (NYSE: PSN) concerning potential violations of the federal securities laws.

Parsons released its fourth quarter 2024 financial results on February 19, 2025, falling short of its prior guidance in revenue and EBITDA. The Company explained that its “adjusted EBITDA growth for the quarter was negatively impacted by $29 million of adjustments on two programs.” Following this news, the price of Parsons shares fell from $73.50 per share on February 18, 2025, to close at $65.08 on February 19, 2025.

If you suffered a loss on your Parsons Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Parsons Corporation which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Parsons Corporation. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join UnitedHealth Group Incorporated Class Action Lawsuit: UNH Lawsuit Sign Up Form

Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired UnitedHealth Group Incorporated (NYSE: UNH) securities.

If you suffered a loss on your UnitedHealth Group Incorporated investment and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

THE LAWSUIT: Dec 03 2024 - Apr 16 2025

CASE DETAILS: The filed complaint alleges that UnitedHealth Group Incorporated made materially false and/or misleading statements and/or failed to disclose that: (1) UnitedHealth had, for years, engaged in a corporate strategy of denying health coverage in order to boost its profits, and ultimately, its share price; (2) this anti-consumer strategy resulted in regulatory scrutiny against UnitedHealth, which ultimately resulted in the murder of Brian Thompson; (3) animus towards UnitedHealth was such that, subsequent to the murder of Mr. Thompson, many Americans openly celebrated his demise, expressed admiration for his accused killer, and/or otherwise demanded that UnitedHealth change its strategy even if they condemned Mr. Thompson’s killing; (4) the foregoing regulatory and public outrage caused UnitedHealth to change its corporate practices; (5) notwithstanding the foregoing, UnitedHealth recklessly stuck with the guidance it issued the day before Thompson’s murder, which was unrealistic considering the Company’s changing corporate strategies; and (6) as a result, defendants’ public statements were materially false and/or misleading at all relevant times.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in UnitedHealth Group Incorporated which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against UnitedHealth Group Incorporated. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join AMC Networks Inc. Class Action Lawsuit: AMCX Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into AMC Networks Inc. (NASDAQ: AMCX) concerning potential violations of the federal securities laws.

AMC issued a press release on February 14, 2025, reporting its financial results for the fourth quarter and full year ended December 31, 2024. Among other items, for the quarter, AMC reported a net loss of $284.5 million, or $6.38 per share, compared to a net loss of $21.8 million, or $0.50 per share, for the same period in 2023. AMC also reported a year-over-year decline in free cash flow for the quarter, to $37.6 million from $66 million, and a significant increase in operating loss, to $254.2 million from $11 million. AMC also recorded more than $345 million in impairment and restructuring charges for the quarter. Following this news, AMC's stock price fell over 10% on the same day.

If you suffered a loss on your AMC Networks Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in AMC Networks Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against AMC Networks Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Supernus Pharmaceuticals, Inc. Class Action Lawsuit: SUPN Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) concerning potential violations of the federal securities laws.

On February 19, 2025, The company announced that its Phase 2b study of SPN-820 for treatment-resistant depression failed to meet its primary endpoint, showing no significant improvement over placebo. This outcome comes as a surprise to investors, given the company's previous optimism surrounding the drug’s potential. Following this news, shares of Supernus Pharmaceuticals fell over 13% in trading.

If you suffered a loss on your Supernus Pharmaceuticals, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Supernus Pharmaceuticals, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Supernus Pharmaceuticals, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Barclays PLC Class Action Lawsuit: BCS Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Barclays PLC (NASDAQ: BCS) concerning potential violations of the federal securities laws.

On February 13, 2025, Barclays disclosed in its annual report for 2024 that the U.K.'s Financial Conduct Authority was investigating whether financial controls at the Company's U.K. division had been too lax and whether Barclays had violated anti-money laundering laws. Following this news, Barclay's American Depositary Receipt ("ADR") price fell over 5% on the same day.

If you suffered a loss on your Barclays PLC securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Barclays PLC which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Barclays PLC. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Amphastar Pharmaceuticals, Inc. Class Action Lawsuit: AMPH Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) concerning potential violations of the federal securities laws.

On November 6, 2024, Amphastar received a secondary complete response letter (CRL) from the Food and Drug Administration (FDA) for its generic teriparatide ANDA, AMP-015, following months of delays surrounding the submission of the drug. Analysts expressed disappointment at the Company’s announcement and Amphastar has still not responded to the CRL. Following this news, Amphastar’s stock price fell by $7.31 per share, or approximately 13% to close at $46.09 per share on November 7, 2024.

If you suffered a loss on your Amphastar Pharmaceuticals, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Amphastar Pharmaceuticals, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Amphastar Pharmaceuticals, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join PDF Solutions, Inc. Class Action Lawsuit: PDFS Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into PDF Solutions, Inc. (NASDAQ: PDFS) concerning potential violations of the federal securities laws.

On February 13, 2025, PDF issued a press release announcing their fourth-quarter and full-year total revenues for 2024. Despite reporting solid results, operating expenses increased and their accounts receivable balance was elevated at the end of the quarter. In addition, PDF faces challenges in aligning customer data for AI applications, which may impact the adoption of their AI-related products. Following this news, PDF’s stock price fell by $0.66 to open at $27.42 per share on February 14, 2025.

If you suffered a loss on your PDF Solutions, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in PDF Solutions, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against PDF Solutions, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Oscar Health, Inc. Class Action Lawsuit: OSCR Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Oscar Health, Inc. (NYSE: OSCR) concerning potential violations of the federal securities laws.

Oscar Health reported mixed earnings performance for the fourth quarter including a greater than expected loss of $0.62 per share. Following this news, shares of Oscar Health fell sharply. The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.

If you suffered a loss on your Oscar Health, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Oscar Health, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Oscar Health, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join STAAR Surgical Company Class Action Lawsuit: STAA Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into STAAR Surgical Company (NASDAQ: STAA) concerning potential violations of the federal securities laws.

Staar reported disappointing earnings for Q4 2024, blaming the results on weak demand in China and a drop in refractive procedures. Following this news, shares of Staar fell over 24% on February 12, 2025. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

If you suffered a loss on your STAAR Surgical Company securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in STAAR Surgical Company which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against STAAR Surgical Company. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Voyager Therapeutics, Inc. Class Action Lawsuit: VYGR Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Voyager Therapeutics, Inc. (NADAQ: VYGR) concerning potential violations of the federal securities laws.

Voyager issued a press release on February 11, 2025, "announc[ing] it has decided to assess alternate payloads related to its gene therapy program for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS)", stating that "[e]merging preclinical data indicate the siRNA payload component of VY9323 does not meet our high standards due to what appears to be an off-target effect resulting in a narrowed therapeutic window." Voyager further stated that it "no longer anticipates filing an investigational new drug (IND) application for VY9323 in mid-2025." Following this new, Voyager's stock price fell over 20% on February 11, 2025.

If you suffered a loss on your Voyager Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Voyager Therapeutics, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Voyager Therapeutics, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join ePlus inc. Class Action Lawsuit: PLUS Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into ePlus inc. (NASDAQ: PLUS) concerning potential violations of the federal securities laws.

On November 12, 2024, after months of reiterating guidance, ePlus published second quarter results lowering guidance. Management attributed the lowered guidance to “ratable and subscription revenue models and slower product sales.” Analysts responded to the news with lowered EPS estimates and price targets. Following this news, ePlus’ stock price fell 16% to close at $79.98 per share on November 13, 2024. On February 5, 2025, ePlus published third quarter results, once again lowering guidance. This time, ePlus management attributed the disappointing news to “lower product sales and a higher proportion of netted down product revenues.” Analysts quickly reacted to the news, lowering EPS estimates and price targets for ePlus. Following this news, ePlus’ stock price fell over 13% to close at $70.29 per share on February 6, 2025.

If you suffered a loss on your ePlus inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in ePlus inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against ePlus inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Harmonic Inc. Class Action Lawsuit: HLIT Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Harmonic Inc. (NASDAQ: HLIT) concerning potential violations of the federal securities laws.

Harmonic reported its third quarter financial results on February 10, 2025. While the Company's reported better-than-expected results for the quarter, it also lowered its revenue guidance for the fourth quarter. The Company's full-year 2025 guidance was also weaker than expected. Following this news, shares of Harmonic fell sharply in after hours trading on the same day. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

If you suffered a loss on your Harmonic Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Harmonic Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Harmonic Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Eldorado Gold Corporation Class Action Lawsuit: EGO Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Eldorado Gold Corporation (NYSE: EGO) concerning potential violations of the federal securities laws.

Eldorado Gold issued a press release on February 5, 2025, in which it provided an update on the construction progress on its Skouries Project. In pertinent part, this announcement stated that “[a]s previously disclosed, labour market tightness in Greece, particularly pronounced in construction, has continued to limit the availability of key construction personnel at Skouries, resulting in a slower ramp-up of the workforce and delayed progress in certain areas of the Project.” Further, Eldorado announced that “[f]irst production at Skouries is now expected in the first quarter of 2026, followed by commercial production expected in mid-2026.” Following this news, the price of Eldorado Gold stock fell over 11% on February 6, 2025.

If you suffered a loss on your Eldorado Gold Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Eldorado Gold Corporation which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Eldorado Gold Corporation. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Pagaya Technologies Ltd. Class Action Lawsuit: PGY Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Pagaya Technologies Ltd. (NASDAQ: PGY) concerning potential violations of the federal securities laws.

On February 11, 2025, Iceberg Research issued a report alleging the company misled investors about its financial health and exposure to risk. The report claims that Pagaya used investor funds to absorb high-risk loan tranches, contradicting its public claims about risk distribution, and engaged in questionable financial maneuvers to inflate fees and attempt to mask impairments. Following this news, shares of Pagaya Technologies fell over 13% on the same day.

If you suffered a loss on your Pagaya Technologies Ltd. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Pagaya Technologies Ltd. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Pagaya Technologies Ltd. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Pliant Therapeutics, Inc. Class Action Lawsuit: PLRX Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Pliant Therapeutics, Inc. (NASDAQ: PLRX) concerning potential violations of the federal securities laws.

On February 7, 2025, Pliant announced that following a prespecified data review and recommendations by the trial’s independent Data Safety Monitoring Board, it had voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis. Following this news, PLRX’s stock price plummeted over 60% to open at $3.02 per share on February 10, 2025.

If you suffered a loss on your Pliant Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Pliant Therapeutics, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Pliant Therapeutics, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Dominion Energy, Inc. Class Action Lawsuit: D Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Dominion Energy, Inc. (NYSE: D) concerning potential violations of the federal securities laws.

On February 3, 2025, Dominion issued a press release providing updates for its Coastal Virginia Offshore Wind (CVOW) project. Among other updates, Dominion stated that estimate total project costs had increased approximately 9% to $10.7 billion from its previous estimate of $9.8 billion. Dominion's stock price fell $2.36 per share following this news.

If you suffered a loss on your Dominion Energy, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Dominion Energy, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Dominion Energy, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Olin Corporation Class Action Lawsuit: OLN Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Olin Corporation (NYSE: OLN) concerning potential violations of the federal securities laws.

Olin issued a press on January 30, 2025, reporting its financial results for the fourth quarter of 2024. Olin also issued guidance for the first quarter of 2025, including adjusted EBITDA of $150 million to $170 million, falling well short of the $227.1 million analyst consensus estimate. Olin cited "challenging industry conditions" "as commercial customers continue to work down elevated inventories along with softer consumer demand," global epoxy demand remains weak, and its U.S. and European epoxy business "remains significantly challenged by subsidized Asian competition." Following this news, Olin's stock price fell over 8% on January 31, 2025.

If you suffered a loss on your Olin Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Olin Corporation which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Olin Corporation. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Primis Financial Corp. Class Action Lawsuit: FRST Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Primis Financial Corp. (NASDAQ: FRST) concerning potential violations of the federal securities laws.

Primis issued a press release on January 28, 2025, reporting certain financial results for the fourth quarter of 2024. Among other items, Primis "reported a net loss available to common shareholders of $14.7 million or $0.59 loss per basic and diluted share for the quarter ended December 31, 2024, compared to a net loss available to common shareholders of $8.2 million or $0.33 loss per basic and diluted share for the quarter ended December 31, 2023." Primis said that its "[e]arnings . . . [were] highly affected by the Company's decision to move a third-party originated consumer loan portfolio to held for sale in the fourth quarter of 2024". Following this news, Primis's stock price fell over 8% on January 29, 2025.

If you suffered a loss on your Primis Financial securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Primis Financial Corp. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Primis Financial Corp. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join MSCI Inc. Class Action Lawsuit: MSCI Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into MSCI Inc. (NYSE: MSCI) concerning potential violations of the federal securities laws.

On January 29, 2025, MSCI reported a 24.3% fall in 4Q profit stemming from an increase in operating expenses, as well as spending on employee incentives and compensation. Following this news, MSCI’s stock price fell by $35.29 per share, or approximately 5% to close at $593.05 per share.

If you suffered a loss on your MSCI Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in MSCI Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against MSCI Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Zentalis Pharmaceuticals, Inc. Class Action Lawsuit: ZNTL Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) concerning potential violations of the federal securities laws.

Zentalis issued a press release on January 28, 2025, "announc[ing] a restructuring of its business operations and research and development organization to support execution of late-stage development for its WEE1 inhibitor product candidate, azenosertib, and extend its cash runway beyond a data readout from its potentially registration-enabling DENALI Part 2 study, anticipated by the end of 2026." Zentalis stated that "[t]he workforce reduction is expected to be substantially completed in the second quarter of 2025." Following this news, Zentalis's stock price fell sharply during intraday trading on January 29, 2025.

If you suffered a loss on your Zentalis Pharmaceuticals, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Zentalis Pharmaceuticals, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Zentalis Pharmaceuticals, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join CARGO Therapeutics, Inc. Class Action Lawsuit: CRGX Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into CARGO Therapeutics, Inc. (NASAQ: CRGX) concerning potential violations of the federal securities laws.

On January 29, 2025, CARGO announced in a press release that it "has elected to discontinue FIRCE-1, a Phase 2 clinical study of firi-cel for patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19 CAR T-cell therapy." The Company continued, "Based on an ad hoc analysis of FIRCE-1 prompted by recent safety events, the Company believes the results do not support a competitive benefit-risk profile of firi-cel for the intended patient population. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

If you suffered a loss on your CARGO Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in CARGO Therapeutics, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against CARGO Therapeutics, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Synchrony Financial Class Action Lawsuit: SYF Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Synchrony Financial (NYSE: SYF) concerning potential violations of the federal securities laws.

Synchrony issued a press release on January 28, 2025, announcing its financial results for the fourth quarter of 2024. Among other items, Synchrony's earnings for the quarter missed consensus estimates, as the Company's net interest income was weaker than expected, its provision for credit card losses exceeded analyst estimates, and its net charge-off rate rose. Following this news, Synchrony's stock price fell sharply during intraday trading on the same day.

If you suffered a loss on your Synchrony Financial securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Synchrony Financial which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Synchrony Financial. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join XPLR Infrastructure, LP Class Action Lawsuit: XIFR Lawsuit Sign Up Form

Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired XPLR Infrastructure, LP (NYSE: XIFR) securities.

If you suffered a loss on your XPLR Infrastructure, LP investment and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

THE LAWSUIT: Jan 26 2021 - Jan 27 2025

CASE DETAILS: The filed complaint alleges that XPLR Infrastructure, LP made materially false and/or misleading statements and/or failed to disclose that: (i) XPLR was struggling to maintain its operations as a yieldco; (ii) defendants temporarily relieved this issue by entering into CEPF, convertible equity portfolio financing arrangements while downplaying the attendant risks; (iii) XPLR could not buy out CEPFs before their maturity date without risking significant unitholder dilution; (iv) as a result, defendants planned to halt cash distributions to investors and instead redirect those funds to, inter alia, buy out the Company’s CEPFs; (v) as a result of all the foregoing, XPLR’s yieldco business model and distribution growth rate was unsustainable; and (vi) as a result, defendants’ public statements were materially false and misleading at all relevant times.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in XPLR Infrastructure, LP which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against XPLR Infrastructure, LP. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Midland States Bancorp, Inc. Class Action Lawsuit: MSBI Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Midland States Bancorp, Inc. (NASDAQ: MSBI) concerning potential violations of the federal securities laws.

Midland States Bancorp announced its financial results for the fourth quarter of 2024 on January 23, 2025. Among other items, the Company reported a loss of $2.52 per diluted share, falling short of the Zacks Consensus Estimate of $0.70 and representing a significant year-over-year decline from earnings of $0.89 per share in the fourth quarter of 2023. Following this news, Midland States Bancorp's stock price fell over 20% on January 24, 2025.

If you suffered a loss on your Midland States Bancorp, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Midland States Bancorp, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Midland States Bancorp, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Spyre Therapeutics, Inc. Class Action Lawsuit: SYRE Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Spyre Therapeutics, Inc. (NASDAQ: SYRE) concerning potential violations of the federal securities laws.

On November 18, 2024, Spyre disclosed in a filing with the U.S. Securities and Exchange Commission "that the Company's previously issued audited consolidated financial statements as of December 31, 2023 and for the year and the second and third quarter interim periods within the year then ended, and its unaudited consolidated financial statements for the quarterly and year-to-date (as applicable) periods ended March 31, 2024, June 30, 2024 and 2023, and September 30, 2024 and 2023 (collectively, the ‘Affected Financial Statements' and such periods, the ‘Affected Periods') should no longer be relied upon" due to "a misapplication of Generally Accepted Accounting Principles in the United States . . . as it relates to the Company's exclusion of its Series A and Series B non-voting convertible preferred stock in the calculation of basic and diluted net loss per share and a finding of material weakness in internal control over financial reporting solely related to such matter." Accordingly, Spyre advised that it "intends to file amendments to the Annual Report on Form 10-K and each of the Quarterly Reports on Form 10-Q for the Affected Periods to correct the net loss per share figures as soon as possible." Following this news, Spyre's stock price drastically fell during intraday trading on November 19, 2024.

If you suffered a loss on your Spyre Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Spyre Therapeutics, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Spyre Therapeutics, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Electronic Arts Inc. Class Action Lawsuit: EA Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Electronic Arts Inc. (NASDAQ: EA) concerning potential violations of the federal securities laws.

On January 22, 2025, EA issued a press release pre-announcing their preliminary Q3 FY25 results and announcing a guide-down from the company’s prior expectations. Where “EA’s initial guidance for fiscal year 2025 anticipated mid-single-digit growth in live services net bookings … the company now projects a mid-single-digit decline.” EA primarily pointed to two setbacks: Global Football, specifically EA Sports FC 25, which required “a comprehensive gameplay refresh” earlier this month; and Dragon Age, which engaged approximately 1.5 million players during the quarter, down nearly 50% from the company’s expectations.” Following this news, EA’s stock price fell by $24.12 per share and is currently trading at $118.23 per share.

If you suffered a loss on your Electronic Arts Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Electronic Arts Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Electronic Arts Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Construction Partners, Inc. Class Action Lawsuit: ROAD Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Construction Partners, Inc. (NASDAQ: ROAD) concerning potential violations of the federal securities laws.

On January 23, 2025, Spruce Point Capital Management published a report highlighting the increasing pressures faced by Construction Partners suggesting that the share price could have a 35-50% potential long-term downside risk. The Spruce Point report focused on Construction Partners’ major decline in contracts from its largest customer, Florida Department of Transportation, and a weak expansion into Texas, which was portrayed as a strong acquisition for the company. The report concluded that the market had miscalculated Construction Partners’ enterprise value, which in turn, reflects a misunderstanding of the company’s business and financial prospects, thus, predicting the 35-50% downside potential. Following this news, Construction Partners’ stock price plummeted over 8% to open at $85.17 per share on January 23, 2025

If you suffered a loss on your Construction Partners, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Construction Partners, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Construction Partners, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Triumph Financial, Inc. Class Action Lawsuit: TFIN Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Triumph Financial, Inc. (NASDAQ: TFIN) concerning potential violations of the federal securities laws.

On January 22, 2025, after market close, Triumph published a quarterly earnings report stating that it had a profit of $0.13 per share, missing the Zacks Consensus Estimate of $0.26 per share by 50%. Triumph CEO Aaron Graft also stated that first quarter 2025 earnings are expected to be even lower, operating expenses are expected to increase, and that the company does not anticipate material revenue will be generated from recently announced initiatives during the first half of 2025. Following this news, Triumph’s stock price fell 3.6% to open at $88.70 per share on January 23, 2025.

If you suffered a loss on your Triumph Financial, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Triumph Financial, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Triumph Financial, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join JinkoSolar Holding Co., Ltd. Class Action Lawsuit: JKS Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into JinkoSolar Holding Co., Ltd. (NYSE: JKS) concerning potential violations of the federal securities laws.

JinkoSolar issued a press release on January 17, 2025, reporting "estimates for certain preliminary unaudited financial results" for 2024 for "its majority-owned principal operating subsidiary, Jinko Solar Co., Ltd." Among other items, JinkoSolar estimated 2024 net income in the range of 80 million yuan to 120 million yuan ($10.92 million to $16.37 million), equating to a decline of more than 98%. JinkoSolar also expects to report full-year preliminary unaudited net loss attributable to shareholders excluding extraordinary gains and losses in the range of 750 million yuan to 1.05 billion yuan, representing a decrease of 100.8% to 115.2%. Following this news, JinkoSolar's American depositary receipt ("ADR") price fell over 9% on the same day.

If you suffered a loss on your JinkoSolar Holding Co., Ltd. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in JinkoSolar Holding Co., Ltd. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against JinkoSolar Holding Co., Ltd. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join CECO Environmental Corp. Class Action Lawsuit: CECO Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into CECO Environmental Corp. (NASDAQ: CECO) concerning potential violations of the federal securities laws.

CECO issued a press release on January 16, 2025, "announc[ing] preliminary financial results for the fourth quarter and full year 2024 and provid[ing] an update on further portfolio transformation." Among other items, CECO lowered its 2024 revenue guidance to the range of $555 million to $558 million, compared to its previous guidance of $575 million to $600 million. CECO also announced its intent to divest its Fluid Handling business by the end of the first quarter of 2025 and to use the sale proceeds to pay down debt and position the Company's balance sheet for future strategic growth investments. Following this news, CECO's stock price fell over 7% on January 17, 2025.

If you suffered a loss on your CECO Environmental Corp. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in CECO Environmental Corp. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against CECO Environmental Corp. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Agilysys, Inc. Class Action Lawsuit: AGYS Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Agilysys, Inc. (NASDAQ: AGYS) concerning potential violations of the federal securities laws.

On January 21, 2025, after the market closed, Agilysys issued a press release announcing third quarter revenue below expectations and the company’s own guidance, resulting in a significant revision to Agilysys’ FY25 revenue guidance. CEO Srinivasan admitted they “underestimated the sales challenges on the point-of-sale POS side of the equation,” that the year “could have been a lot better,” and that they “could have also done a lot better with the speed of hiring for the implementation services teams.” Following this news, on January 22, 2024, Agilysys’ stock price fell by $25.23 per share to close at $100.67 per share.

If you suffered a loss on your Agilysys, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Agilysys, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Agilysys, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join IGM Biosciences, Inc. Class Action Lawsuit: IGMS Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into IGM Biosciences, Inc. (NASDAQ: IGMS) concerning potential violations of the federal securities laws.

IGM issued a press release on January 9, 2025, "announc[ing] a strategic update to halt further development of imvotamab, an IgM-based CD20 X CD3 bispecific antibody T cell engager, and IGM-2644, an IgM-based CD38 X CD3 bispecific antibody T cell engager, for autoimmune diseases." The press release quoted Mary Beth Harler, M.D., the Company's Chief Executive Officer, as stating that "[i]nterim data from the Phase 1b studies of imvotamab in rheumatoid arthritis and systemic lupus erythematosus show that the depth and consistency of B cell depletion is insufficient to meet our high bar for success[.]" Following this news, IGM's stock price fell over 66% on January 10, 2025.

If you suffered a loss on your IGM Biosciences, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in IGM Biosciences, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against IGM Biosciences, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Polestar Automotive Holding UK PLC Class Action Lawsuit: PSNY Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Polestar Automotive Holding UK PLC (NASDAQ: PSNY) concerning potential violations of the federal securities laws.

On January 16, 2025, Polestar filed a report with the U.S. Securities and Exchange Commission (SEC). The report, a Form 6-K, revealed that the company had identified errors in its previously reported financial statements. These errors affect the audited financial reports for the years ending December 31, 2022, and December 31, 2023, as well as unaudited financial reports for interim periods between September 30, 2022, and June 30, 2024. Polestar announced that it would need to restate these financial documents, including the interim financials for the six-month periods ending June 30, 2023, and June 30, 2024. Following this news, Polestar's Class A American Depositary Shares (ADS) fell over 11% during intraday trading on the same day.

If you suffered a loss on your Polestar Automotive Holding UK PLC securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Polestar Automotive Holding UK PLC which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Polestar Automotive Holding UK PLC. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Signet Jewelers Limited Class Action Lawsuit: SIG Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Signet Jewelers Limited (NYSE: SIG) concerning potential violations of the federal securities laws.

On January 14, 2025, Signet issued a press release announcing the company’s holiday sales results, comprising the 10-week period ending January 11, 2025, and significantly underperformed compared to expectations. Signet blamed the underperformance on a slump in fashion gifting “as consumers gravitated to lower price points even more than anticipated in a continued competitive environment.” Due to the impact of the company’s poor holiday performance, Signet reduced its guidance across the board for the current fourth quarter of fiscal year 2025. Following this news, Signet’s stock price fell by $17.98 per share and is currently trading at $56.06 per share.

If you suffered a loss on your Signet securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Signet Jewelers Limited which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Signet Jewelers Limited. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Johnson & Johnson Class Action Lawsuit: JNJ Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Johnson & Johnson (NYSE: JNJ) concerning potential violations of the federal securities laws.

J&J issued a press release on January 8, 2025, announcing that "on January 5, out of an abundance of caution, Johnson & Johnson MedTech temporarily paused the U.S. External Evaluation and all U.S. VARIPULSE™ cases while we investigate the root cause of four reported neurovascular events in the U.S. External Evaluation." Following this news, J&J's stock price fell over 2% on the same day.

If you suffered a loss on your Johnson & Johnson securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Johnson & Johnson which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Johnson & Johnson. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join MicroCloud Hologram Inc. Class Action Lawsuit: HOLO Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into MicroCloud Hologram Inc. (NASDAQ: HOLO) concerning potential violations of the federal securities laws.

On January 8, 2025, MicroCloud and several other quantum computing stocks, fell drastically after Nvidia CEO Jensen Huang stated that "very useful quantum computers" are likely 20 years away. Following this news, MicroCloud stock fell over 30% on the same day.

If you suffered a loss on your MicroCloud Hologram Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in MicroCloud Hologram Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against MicroCloud Hologram Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Rigetti Computing, Inc. Class Action Lawsuit: RGTI Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Rigetti Computing, Inc. (NASDAQ: RGTI) concerning potential violations of the federal securities laws.

On January 8, 2025, Rigetti and several quantum computing stocks, fell drastically after Nvidia CEO Jensen Huang stated that "very useful quantum computers" are likely 20 years away. Following this news, Rigetti stock fell over 45% on the same day.

If you suffered a loss on your Rigetti Computing, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Rigetti Computing, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Rigetti Computing, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Inspired Entertainment, Inc. Class Action Lawsuit: INSE Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Inspired Entertainment, Inc. (NASDAQ: INSE) concerning potential violations of the federal securities laws.

Inspired Entertainment, Inc., a gaming technology company, announced on November 8, 2023, that it had discovered accounting errors in its financial statements dating back to January 1, 2021, primarily related to the capitalization of software development costs under U.S. GAAP standards. These errors required the company to restate its financial results for these periods, and thus, Inspired Entertainment delayed releasing its third-quarter 2023 financial results to address the issue. The Audit Committee of the Board of Directors of the Company then determined that the Company’s financial statements, including press releases, earnings statements, investor presentations, and issued reports, made January 1, 2021, and onwards, should no longer be relied upon and require restatement. A broader review of the company’s accounting practices is underway, with input from its current independent accounting firm, though the extent of further adjustments remains unclear. Following this news, the price of Inspired Entertainment shares fell over 29% on November 9, 2023.

If you suffered a loss on your Inspired Entertainment, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Inspired Entertainment, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Inspired Entertainment, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Carvana Co. Class Action Lawsuit: CVNA Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Carvana Co. (NYSE: CVNA) concerning potential violations of the federal securities laws.

On January 2, 2025, Carvana became the subject of a report published by Hindenburg Research. The report, titled: "Carvana: A Father-Son Accounting Grift For The Ages," alleges that the Company's turnaround is a "mirage." The report claims, "Our research uncovered $800 million in loan sales to a suspected undisclosed related party, along with details on how accounting manipulation and lax underwriting have fueled temporary reported income growth - all while insiders cash out billions in stock." The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

If you suffered a loss on your Carvana Co. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Carvana Co. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Carvana Co. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Vail Resorts, Inc. Class Action Lawsuit: MTN Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Vail Resorts, Inc. (NYSE: MTN) concerning potential violations of the federal securities laws.

Seeking Alpha reported on January 2, 2025, that Vail shares "have come under increased selling pressure . . . as the strike by 200 members of the Park City Professional Ski Patrol Association continues without a satisfactory offer from the company", which "has now garnered support from ski patrols at Vail Resorts' other locations." Seeking Alpha further reported that "[t]o keep the slopes open during the holiday week, Vail Resorts . . . has reassigned patrollers from its Breckenridge, Crested Butte, and Keystone resorts to fill in for striking members at Park City", but that "by transferring patrol from one resort to another, the company risks damaging workforce morale and creating an unsafe environment for guests." Following this news, Vail Resorts' stock price fell over 6% on the same day.

If you suffered a loss on your Vail Resorts, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Vail Resorts, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Vail Resorts, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Dave Inc. Class Action Lawsuit: DAVE Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Dave Inc. (NASDAQ: DAVE) concerning potential violations of the federal securities laws.

Morningstar reported on December 31, 2024, that Dave recently announced updates to its fee structure in response to issues raised in the FTC's lawsuit, which was amended by the DOJ earlier this week. According to Morningstar, the FTC, initially filed a complaint in November 2024, accusing Dave of misleading marketing practices related to its cash advance services. According to Morningstar, on December 30, 2024, the DOJ amended its complaint to include Dave's CEO, Jason Wilk, as a named defendant. The amended complaint alleges that Dave and its CEO engaged in deceptive practices by imposing hidden fees and using a misleading app interface that encouraged users to provide substantial tips without offering a transparent option to avoid tipping. The DOJ is seeking civil penalties in the case. Following this news, shares of Dave Inc. stock fell over 10% during intraday trading on December 31, 2024.

If you suffered a loss on your Dave Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Dave Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Dave Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Sangamo Therapeutics, Inc. Class Action Lawsuit: SGMO Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Sangamo Therapeutics, Inc. (NASDAQ: SGMO) concerning potential violations of the federal securities laws.

Sangamo announced on December 30, 2024, that Pfizer, with whom the Company was co-developing hemophilia A gene therapy candidate giroctocogene fitelparvovec, would be returning after the development and commercialization rights to giroctocogene fitelparvovec after deciding not to pursue commercialization of the asset, which is in phase 3. Sangamo stated in a press release announcing this development, that it was "surprised and extremely disappointed by Pfizer's decision" to end the collaboration so close to anticipated Biologics License Application and Marketing Authorisation Application submissions for giroctocogene fitelparvovec, which the Company had expected to occur in early 2025. The collaboration and license agreement with Pfizer will terminate effective April 21, 2025, at which time Pfizer will be required to transition the giroctocogene fitelparvovec program back to Sangamo. Following this news, Sangamo's stock price fell during intraday trading on December 31, 2024.

If you suffered a loss on your Sangamo Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Sangamo Therapeutics, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Sangamo Therapeutics, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Walmart Inc. Class Action Lawsuit: WMT Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Walmart Inc. (NYSE: WMT) concerning potential violations of the federal securities laws.

The Consumer Financial Protection Bureau ("CFPB") announced on December 23, 2024, that it had filed a lawsuit against Walmart and Branch Messenger for forcing delivery drivers to use costly deposit accounts to get paid and for deceiving workers-"last mile" drivers in Walmart's Spark Driver program-about how they could access their earnings. The CFPB's lawsuit alleges that Walmart and Branch opened Branch accounts for Spark Drivers, and Walmart then deposited drivers' pay into these accounts, without the drivers' consent. According to the CFPB, Walmart told Spark Drivers that they were required to use Branch to get paid and that they would terminate workers who did not want to use these accounts. Further, Walmart and Branch also misled workers about the availability of same-day access to their earnings. In addition, in a press release announcing the lawsuit, the CFPB stated that "[d]rivers had to follow a complex process to access their funds, and when they finally did, they faced further delays or fees if they needed to transfer the money they earned into an account of their choice. This resulted in workers paying more than $10 million in fees to transfer their earnings to an account of their choice." Following this news, Walmart's stock price fell sharply during intraday trading on the same day.

If you suffered a loss on your Walmart Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Walmart Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Walmart Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join XBiotech Inc. Class Action Lawsuit: XBIT Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into XBiotech Inc. (NASDAQ: XBIT) concerning potential violations of the federal securities laws.

XBiotech announced on December 23, 2024, that it was pausing a phase 2 rheumatoid arthritis program after the candidate, Natrunix, failed to meet its primary endpoint. Specifically, the Company noted that "substantial irregularities that make unequivocal interpretation of the findings difficult." Following this news, XBiotech's stock price sharply fell during intraday trading on the same day.

If you suffered a loss on your XBiotech Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in XBiotech Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against XBiotech Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Vertex Pharmaceuticals Incorporated Class Action Lawsuit: VRTX Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) concerning potential violations of the federal securities laws.

On December 19, 2024, the company reported disappointing results from its RewinD-LB Phase 2b clinical trial for the pain drug suzetrigine. The trial, which targeted pain caused by a pinched nerve in the spine, showed no significant difference in pain reduction compared to a placebo. The company also announced plans to proceed with a Phase 3 trial for suzetrigine, a decision that has left some analysts questioning the rationale. One commentator stated on X "Vertex often gets the benefit of the doubt given its track record, but damn, this one is tough to reconcile." The company's announcements come mere days after insider transactions have been reported. Following this news, shares of Vertex fell 12% in morning trading on the same day.

If you suffered a loss on your Vertex Pharmaceuticals securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Vertex Pharmaceuticals Incorporated which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Vertex Pharmaceuticals Incorporated. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Sezzle Inc. Class Action Lawsuit: SEZL Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Sezzle Inc. (NASDAQ: SEZL) concerning potential violations of the federal securities laws.

On December 18, 2024, Hindenburg Research accused the company of engaging in unsustainable lending practices funded by high-interest loans, overstating its customer and merchant base, and allowing insiders to profit through margin loans. Hindenburg Research's report raises concerns regarding Sezzle’s financial health, and Sezzle's business model. Following this news, shares of Sezzle fell over 22% on the same day.

If you suffered a loss on your Sezzle Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Sezzle Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Sezzle Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Sapiens International Corporation N.V. Class Action Lawsuit: SPNS Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Sapiens International Corporation N.V. (NASDAQ: SPNS) concerning potential violations of the federal securities laws.

On November 8, 2024, Sapiens International reported 3Q 2024 earnings that fell well below expectations and then lowered its guidance for the year and predicted single-digit revenue growth for 2025. Management attributed the decrease to continued delays in deal closings, a larger-than-anticipated impact from clients moving to SaaS solutions from on-premises solutions, and an increase in competition in North America. Analysts expressed concerns regarding the Company’s weak performance in North America, noting a decline in revenue growth as the SaaS transition and economic uncertainty is leading to longer sales cycles. Following this news, SPNS’s stock price fell by $10.35 per share, or approximately 26.24% to close at $29.10 per share.

If you suffered a loss on your Sapiens International Corporation N.V. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Sapiens International Corporation N.V. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Sapiens International Corporation N.V. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Enovix Corporation Class Action Lawsuit: ENVX Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Enovix Corporation (NASDAQ: ENVX) concerning potential violations of the federal securities laws.

Analysts expressed concerns about the timing of the company’s early November $100 million public offering announcement. The equity offering was announced shortly after management stated on a Q3 2024 earnings call that the firm had no immediate capital needs. Following the sudden departure of Enovix CFO Farhan Ahmad, shares of Enovix fell over 6% on December 16, 2024.

If you suffered a loss on your Enovix Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Enovix Corporation which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Enovix Corporation. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Keros Therapeutics, Inc. Class Action Lawsuit: KROS Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Keros Therapeutics, Inc. (NASDAQ: KROS) concerning potential violations of the federal securities laws.

Keros issued a press release on December 12, 2024, "announc[ing] that it has voluntarily halted dosing in the 3.0 mg/kg and 4.5 mg/kg treatment arms in the ongoing TROPOS trial, a Phase 2 clinical trial of cibotercept (KER-012) in combination with background therapy in patients with pulmonary arterial hypertension ("PAH"), based on a safety review due to the unanticipated observation of pericardial effusion adverse events in the trial." Following this news, Keros's stock price fell sharply during intraday trading on the same day.

If you suffered a loss on your Keros Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Keros Therapeutics, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Keros Therapeutics, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Genuine Parts Company Class Action Lawsuit: GPC Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Genuine Parts Company (NYSE: GPC) concerning potential violations of the federal securities laws.

On October 22, 2024, Genuine reported 3Q 2024 earnings that fell well below expectations and then lowered its guidance for the year. Management attributed the decrease to weakness in Europe and challenges in its industrial segment. Analysts expressed concern at the Company’s “anemic industrial sales” as well as flat growth in automotive sales. Following this news, GPC’s stock price fell by $30.01 per share, or approximately 21% to close at $113.11 per share.

If you suffered a loss on your Genuine Parts Company securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Genuine Parts Company which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Genuine Parts Company. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Informa TechTarget Class Action Lawsuit: TTGT Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Informa TechTarget (NASDAQ: TTGT) concerning potential violations of the federal securities laws.

TechTarget completed its business combination on December 2, 2024, with Informa Tech, a business unit of Informa PLC ("Informa"). On December 6, 2024 Tech Target disclosed in a filing with the U.S. Securities and Exchange Commission that Informa's management had advised the Company that certain "financial statements previously prepared by Informa should no longer be relied upon and were being restated because of errors identified by Informa in such financial statements". Following this news, TechTarget's stock price fell over 8% on December 9, 2024.

If you suffered a loss on your Informa TechTarget securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Informa TechTarget which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Informa TechTarget. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Conagra Brands, Inc. Class Action Lawsuit: CAG Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Conagra Brands, Inc. (NYSE: CAG) concerning potential violations of the federal securities laws.

On October 2, 2024, Conagra reported 1Q 2025 financial results that reported a decrease in net sales. The Company attributed the lost sales to a “manufacturing disruption” at its Hebrew National hot dog plant. Analysts expressed concern and surprise at the Company’s decrease in organic sales growth. Following this news, CAG’s stock price fell by $2.64 per share, or approximately 8% to close at $30.08 per share.

If you suffered a loss on your Conagra Brands, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Conagra Brands, Inc. which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Conagra Brands, Inc. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1

Join Paladin Energy Ltd Class Action Lawsuit: PALAF Lawsuit Sign Up Form

Levi & Korsinsky notifies investors that it has commenced an investigation into Paladin Energy Ltd (OTC: PALAF) concerning potential violations of the federal securities laws.

Paladin issued an announcement on November 12, 2024, entitled "Langer Heinrich Mine update and revision of FY2025 guidance." In this announcement, Paladin said that "[a]s a result of the lower than expected production results for October, and noting the ongoing challenges and operational variability experienced to date in ramping up production at the [Langer Heinrich Mine], Paladin has determined to revise its FY2025 production guidance to 3.0 - 3.6 Mlb (previously 4.0 - 4.5 Mlb) and withdraw all other guidance in relation to FY2025." Following this news, Paladin stock fell over 24% on the same day.

If you suffered a loss on your Paladin Energy Ltd securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.

Step 1 of 3

Quick First Step

Please provide your address so we can contact you about your case if eligible.

1
1
1
1
1
1
Step 2 of 3

Add Your Transactions

Input your stock purchases and sales

Purchases

+ Additional Purchases

Sales

+ Additional Sales

Alternatively, you may upload your transactions below or e-mail them to [email protected]

1
1
1
1
1
1
Step 2 of 3

Certification of Plaintiff Pursuant to Federal Securities Laws

I, duly certify and say, as to the claims asserted under the federal securities laws, that:

  1. I have reviewed a complaint filed in the action.
  2. I did not purchase the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this action.
  3. I am willing to serve as a representative party on behalf of the class, including providing testimony at deposition and trial, if necessary.
  4. My transaction(s) in Paladin Energy Ltd which are the subject of this litigation during the class period set forth in the complaint are set forth in the chart attached hereto.
  5. Within the last 3 years,
  6. I will not accept any payment for serving as a representative party on behalf of the class beyond the Plaintiff's pro rata share of any recovery, except as ordered or approved by the court, including any award for reasonable costs and expenses (including lost wages) directly relating to the representation of the class.

Are you US Citizen?

Clear

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

By your signature above, you confirm that have retained Levi & Korsinsky, LLP to represent you and the shareholder class as a lead plaintiff in the pending class action against Paladin Energy Ltd. This representation will be on a contingency basis, meaning that Levi & Korsinsky will advance all expenses in the litigation and will only seek compensation and/or reimbursement of expenses if the firm obtains a recovery. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees, expenses, or costs. Should we obtain a favorable result, we may ask the court to award us compensation and reimbursement of expenses to be paid by the defendants or as a portion of any class recovery. In exchange for our representation, you agree to cooperate as our client by providing, for example, relevant documents and deposition testimony, if necessary. During the course of this litigation, we may employ and/or work with other law firms, experts, and third-parties to successfully prosecute this action. If you are not appointed as the lead plaintiff or Levi & Korsinsky is not appointed as lead counsel, we will notify you of such decision at which time this representation will end unless otherwise extended by you and the firm. We look forward to working with you towards a successful resolution of this action.

1
1
1
1
1
1
Step 3 of 3

Upload Your Stock Tickers

Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.

Fast: takes less than a min
We do not create an attorney-client relationship
Your information is confidential & secure

1
1
1
1
1
1